Intractable Pneumothorax Treatment Market By Types (Traumatic Pneumothorax and Nontraumatic Pneumothorax), Drugs Class (Antibiotics, Benzodiazepines, Opiate Anesthetics and Others), Diagnosis (Chest Radiography, CT Scan, Thoracic Ultrasound and Others), Treatment (Medications, Supportive Care and Surgery), Route of Administration (Oral, Inhalation and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Intractable Pneumothorax Treatment Market
Global intractable pneumothorax treatment market is growing at a steady CAGR in the forecast period of 2021-2026. The report contains data of the base year 2018 and historic year 2017. Increasing prevalence of respiratory diseases such as COPD and asthma, increasing aging population across the world, along with the rising healthcare expenditures are certain factors which can augment the growth of this market.
Download full sample report of Intractable Pneumothorax Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-intractable-pneumothorax-treatment-market
Market Definition: Global Intractable Pneumothorax Treatment Market
Intractable pneumothorax is a condition of collapsed lung. This condition occurs when air leaks out in-between the spaces of lung and chest wall. This air puts pressure on the lungs from outside and makes it collapse, this can results in a complete lung collapse or a collapse of only a portion of the lung. Pneumothorax can be caused by chest injuries which penetrates the lungs, certain medical procedures, or from any lung disease. Symptoms include sudden chest pain and shortness of breath.
Market Drivers
- Increasing prevalence of respiratory diseases such as COPD and asthma is driving the market growth
- Availability of effective treatment for the pneumothorax across different regions is boosting the market growth
- Increasing awareness about the various respiratory diseases is expected to drive the market growth
- Rising healthcare expenditures can also act as a driver for the growth of this market
Market Restraints
- Delayed diagnosis and low rate of diagnosis of pneumothorax is hampering the market growth
- Lack of awareness about the pneumothorax in underdeveloped countries as well as developing countries is also hindering the growth of this market
- Limited availability of medicinal treatment options can act as a major restricting factor in this market growth
Segmentation: Global Intractable Pneumothorax Treatment Market
By Types
- Traumatic Pneumothorax
- Nontraumatic Pneumothorax
By Drugs Class
- Antibiotics
- Benzodiazepines
- Opiate Anesthetics
- Others
By Diagnosis
- Chest Radiography
- CT Scan
- Thoracic Ultrasound
- Others
By Treatment
- Medications
- Supportive Care
- Surgery
By Route of Administration
- Oral
- Inhalation
- Parenteral
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By End-Users
- Hospitals
- Homecare
- Specialty Clinics
By Geography
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- K.
- France
- Spain
- Netherlands
- Belgium
- Switzerland
- Turkey
- Russia
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Rest of Asia Pacific
- South America
- Brazil
- Rest of South America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Key Developments in the Market
- In August 2019, Nobelpharma Co., Ltd is developing Unitalc for the treatment of patients with intractable pneumothorax, currently ongoing in phase ll clinical trial. If approved this drug will provide the potential treatment for the patients with pneumothorax
- In May 2019, Zebra Medical Vision, Inc received the 510(k) U.S FDA approval for HealthPNX - an AI alert for pneumothorax, based on chest X-rays. Approval of this device will help in the early diagnosis of pneumothorax further assisting in improving the patient care
Competitive Analysis:
Global intractable pneumothorax treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of intractable pneumothorax treatment drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
The key market players in the global intractable pneumothorax treatment market are Abbott, , Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Vygon SA, Utah Medical Products, Inc, Smiths Group plc, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, , Nobelpharma Co., Ltd, Zebra Medical Vision, Inc among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-intractable-pneumothorax-treatment-market
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-intractable-pneumothorax-treatment-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports @